RxDoctor Payments Data

Ambreen Ghori, MD

Child & Adolescent Psychiatry · Fort Wayne, INNPI 1326458514

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 10 manufacturers reported payments, led by Sunovion Pharmaceuticals Inc. at 43.4% of the total. Reporting peaked in 2020 at $316 and has fallen 87.2% since, to $41 in 2024.

$922in general payments, 2019–2025

Across 35 payments — averaging $26.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sunovion Pharmaceuticals Inc.$400
  • Medtronic$194
  • Nevro Corp.$98
  • Otsuka America Pharmaceutical, Inc.$67
  • Supernus Pharmaceuticals, Inc.$48
  • Lundbeck LLC$40
  • plus $75 from 4 others

What the payments were for

  • Food & beverage$922100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$922 in reported general payments places this provider in the 65th percentile of 56 child & adolescent psychiatry providers in Indiana.

See all child & adolescent psychiatry providers in Indiana

Medicare billing

Part B allowed, 2024
$1,697
Medicare patients
11
Services billed
26

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate51$394,107
Invega SustennaPaliperidone Palmitate51$156,558
Austedo XrDeutetrabenazine21$139,080
RexultiBrexpiprazole38$66,719
VraylarCariprazine Hcl40$64,533
Abilify MaintenaAripiprazole19$46,131
Lurasidone Hcl80$31,528
CaplytaLumateperone Tosylate19$29,048
TrintellixVortioxetine Hydrobromide45$26,008
Aripiprazole117$16,147
FanaptIloperidone12$10,363
BelsomraSuvorexant21$8,622
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl47$7,411
Hydroxyzine Hcl286$6,476
Buspirone Hcl409$5,865

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza$18$394,10751 claims
Teva Pharmaceuticals USA, Inc.Austedo Xr, Loxapine$19$141,27638 claims
Otsuka America Pharmaceutical, Inc.Rexulti, Abilify Maintena$67$112,85157 claims
Vanda Pharmaceuticals Inc.Fanapt$24$10,36312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 56 child & adolescent psychiatry providers in Indiana.

Other child & adolescent psychiatry in Fort Wayne

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →